Weanalyzed the HLAantigens in two patients with rheumatoid arthritis accompanied by diffuse panbronchiolitis in whomHLAtyping could be done and found the presence ofB54 and DR4 alleles. Wepreviously reported that the frequency ofHLA-B54is significantly increased in patients with diffuse panbronchiolitis. This allele demonstrates a linkage disequilibrium with DR4(or DR4.1) in Japanese individuals. The association of rheumatoid arthritis with HLA-DR4 is well established in various ethnic groups including Japanese people. Since both diseases show the same pattern of HLAcorrelation, more Japanese patients with these two diseases are likely to be encountered. (Internal Medicine 33: 612-614, 1994) 
Introduction
Diffuse panbronchiolitis is a clinicopathologic entity found primarily in Japan (1) . The characteristic features of this disorder are chronic recurrent or continuous sinopulmonaryinfection and inflammation, and its histologic features include diffuse respiratory bronchiolitis and peribronchiolitis with predominance in the lower lung fields (1, 2) . In patients with diffuse panbronchiolitis, the frequency of the HLA haplotype, A24/l l-B54-Cwl-DR4 (4.1), is significantly increased (2) . On the other hand, rheumatoid arthritis is also knownto be significantly correlated with HLA-DR4 and B54 in Japanese patients (3) . We have identified 56 patients with diffuse panbronchiolitis, 4 of whomshowed concomitant rheumatoid arthritis. Since both diffuse panbronchiolitis and rheumatoid arthritis showthe samepattern of HLAcorrelation in Japan, it is likely that these two diseases may accompany each other. Wetherefore analyzed the HLAantigens in two patients with both rheumatoid arthritis and diffuse panbronchiolitis and found B54 and DR4 in both. RV/TLC, 44% (175% of predicted). Diffusing capacity (Deo) was normal. Haemophilus influenzae was cultured from her sputum. Chest roentgenogram revealed small nodular shadows with an unclear margin diffusely scattered in both lower lung fields (Fig. 1) . Computer tomography also revealed manysmall nodular shadowslocated in the centrilobular area (Fig. 2) . Diffuse panbronchiolitis was diagnosed on the basis of her history, chest X-ray findings, and laboratory data. Lowdose long-term erythromycin treatment was started, and after three monthsconsiderable regression of both subjective complaints and radiological findings was noted. The response to erythromycin therapy in this patient was not inconsistent with that in diffuse panbronchiolitis (5).
HLAtyping
Typing for HLA-A, B, C, DR and DQ was performed by the NIH standard method as described previously (6) . The specificities of selected antisera obtained locally and from foreign laboratories were defined according to the standards established by the International Histocompatibility Workshop.
Wedefined DR4. 1 by apositive reaction to all three alloantisera, AOH600, AOH602 and TD 511, which are the key sera for determining the serologic "split" of the DR4antigen (7), and the serologically determined DR4. 1 specificity includes the cytologically determined Dwl4, Dwl5, and Dw4 specificities (8). Thepatient's HLAtype was A24, A6-B61, B54-Cwl, CwlO -DR4.1, DR9 -DR53 -DQ3, DQ4.
Patient 2
A 58-year-old non-smoking Japanese housewife had been diagnosed as having rheumatoid arthritis in 1980 and had been treated with nonsteroidal anti-inflammatory drugs and auranofin.
She had no inhalation exposure history. In 1982, she complained of gradually progressive cough and yellow sputum discharge. She had had chronic sinusitis since her childhood.
Her chest roentgenogram, pulmonaryfunction tests and laboratory data revealed that the pulmonary disorder presented features consistent with diffuse panbronchiolitis. HerHLA typing was Al1, A24-B7, B54 -Cwl -DR1, DR4-DR53 -DQ1 , DQ4. Atthe time thatthis HLAtyping was conducted, we could not determine the DR4.1 status, and it is unclear whether the DR4was DR4. quently, the frequency ofDR4 was also increased in the patients in our study (60.0% compared with the control; 37.9%) (2) , and the frequency of HLA-DR4was suggested to be increased due to linkage disequilibrium with the HLA-B54. On the other hand, the association of rheumatoid arthritis with HLA-DR4is well established in various ethnic groups including Japanese (3, 10, 1 1). It has also been reported that the frequencies ofHLA-B54, B59 and DR4 are increased in Japanese patients with rheumatoid arthritis (12). Takeuchi et al also reported the existence of a putative susceptibility haplotype, B54 or B59-C4B5-DR4. 1, in Japanese patients with rheumatoid arthritis (12) .
Recently, DR4 has been divided into DR4.1 and 4.2, the former of which is associated with rheumatoid arthritis (13 panbronchiolitis rather than pulmonary involvement of rheumatoid arthritis. At present, we have collected data regarding 56 cases of diffuse panbronchiolitis; among them, four cases including one autopsied case were complicated by rheumatoid arthritis. Three of the patients had had chronic sinusitis from childhood, and had manifested the symptomsand signs of diffuse panbronchiolitis after the onset of rheumatoid arthritis. Because the frequency of HLA-B54is significantly increased among patients with diffuse panbronchiolitis and since B54 is correlated with DR4 as the extended haplotype, both diffuse panbronchiolitis and rheumatoid arthritis have the same HLA haplotype correlation including B54 and DR4. Therefore, it is likely that more Japanese patients with diffuse panbronchiolitis accompanied by chance with rheumatoid arthritis will be encountered in the future.
Concerning the relationship of rheumatoid arthritis with other pulmonary diseases, accompanying silicosis has been reported (16) . South African gold miners with rheumatoid arthritis are more likely to develop silicosis whenexposed to silica than are miners without rheumatoid arthritis (16) . Furthermore, it has been reported that the frequency of HLA-B54 is also increased in Japanese patients with silicosis (17) .
